Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease
Public ClinicalTrials.gov record NCT05873595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Understanding Through Real-world Data to Validate Effectiveness of Treatments in Peyronie's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.
Study identification
- NCT ID
- NCT05873595
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2023
- Primary completion
- Feb 25, 2024
- Completion
- Feb 25, 2024
- Last update posted
- Apr 15, 2024
2023 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Pharmaceuticals Clinical Site 2 | San Diego | California | 92120 | — |
| Endo Pharmaceuticals Clinical Site 3 | Miami | Florida | 33136 | — |
| Endo Pharmaceuticals Clinical Site 6 | Greenwood | Indiana | 46143 | — |
| Endo Pharmaceuticals Clinical Site 5 | Lansing | Michigan | 48912 | — |
| Endo Pharmaceuticals Clinical Site 7 | Gahanna | Ohio | 43230 | — |
| Endo Pharmaceuticals Clinical Site 4 | Houston | Texas | 77030 | — |
| Endo Pharmaceuticals Clinical Site 1 | Orem | Utah | 84057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05873595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2024 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05873595 live on ClinicalTrials.gov.